Novo Nordisk downgraded as pipeline ‘not poised to blunt semaglutide LOE’
Post Content Read More Stock Market News #stockmarket
Kohl’s forecasts muted annual sales, profit amid stiff competition
Post Content Read More Stock Market News #stockmarket
BofA sees limited upside in Qualcomm stock on lukewarm growth prospects
Post Content Read More Stock Market News #stockmarket
Japan to back IEA joint oil reserve release amid Iran war concerns
Post Content Read More Commodities & Futures News #future
Kremlin says US sanctions relief on Russian oil not discussed in detail
Post Content Read More Commodities & Futures News #future
Morning Bid: Oil’s combustible calm
Post Content Read More Commodities & Futures News #future
Oil demand destruction would likely require prices around $155/bbl: Bernstein
Post Content Read More Commodities & Futures News #future
Morgan Stanley technicals see $134/$150 upside risk for oil prices
Post Content Read More Commodities & Futures News #future
Why JavaScript is a “glue” language
Post Content JavaScript is a “glue” langauge – holding it all together. Sumit talks about why JS is so useful on the freeCodeCamp podcast. Read More freeCodeCamp.org #frecodecamp
Guggenheim Reiterates Buy Rating for Dianthus Therapeutics (DNTH)
Post Content Read More Yahoo Finance #finance
The Structural Risks Investors Should Watch at Interactive Brokers
Post Content Read More Yahoo Finance #finance
Earnings live: Kohl’s stock slides as sales decline, Nio pops, with Oracle earnings on deck
Post Content Read More Yahoo Finance #finance
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
Post Content Read More Yahoo Finance #finance
BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX)
Post Content Read More Yahoo Finance #finance
Is Viking Therapeutics (VKTX) One of the Shorted Biotech Stocks to Invest in
Post Content Read More Yahoo Finance #finance
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s,Qualcomm, Rivian, Strategy and More
Post Content Read More Yahoo Finance #finance
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)
Post Content Read More Yahoo Finance #finance
Wedbush Raises Price Target on Apogee Therapeutics (APGE)
Post Content Read More Yahoo Finance #finance
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Post Content Read More Yahoo Finance #finance